Développement rationnel de nouvelles combinaisons de médicaments dans le cancer colorectal
Les réponses adaptatives fonctionnelles (secondaires à des modulations de la signalisation cellulaire) peuvent contribuer à la résistance des tumeurs humaines aux traitements ciblés. Ce travail vise à caractériser les changements induits par la chimiothérapie dans le phosphokinome de cellules de can...
Main Author: | Tosi, Diego |
---|---|
Other Authors: | Montpellier |
Language: | en |
Published: |
2016
|
Subjects: | |
Online Access: | http://www.theses.fr/2016MONTT058 |
Similar Items
-
Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer
by: Pietro Paolo Vitiello, et al.
Published: (2021-01-01) -
Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy
by: Al-Keilani MS, et al.
Published: (2018-03-01) -
Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs
by: Diana Duarte, et al.
Published: (2021-07-01) -
Turmeric ethanolic extract possesses stronger inhibitory activities on colon tumour growth than curcumin – The importance of turmerones
by: Grace Gar-Lee Yue, et al.
Published: (2016-04-01) -
Salinomycin and Sulforaphane Exerted Synergistic Antiproliferative and Proapoptotic Effects on Colorectal Cancer Cells by Inhibiting the PI3K/Akt Signaling Pathway in vitro and in vivo
by: Liu F, et al.
Published: (2020-06-01)